F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus
F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus
Recruiting · NCT07829614 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2026-09-21 | NCT07829614 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shandong New Time Pharmaceutical Co., LTD | 15 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 9 |